Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I Scher

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
JAMA|May 11, 1999
Management of prostate cancer after prostatectomy: treating the patient, not the PSAH I Scher
Seminars in Oncology|October 1, 1994
Prostate cancer: improving the therapeutic indexH I Scher
The New England Journal of Medicine|November 4, 1993
New approaches to the treatment of bladder cancerH I Scher
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Neoadjuvant versus adjuvant chemotherapy in invasive bladder cancerH I Scher
European Urology|January 1, 1996
Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: the argument forH I Scher
Seminars in Oncology|October 1, 1994
Introduction: prostate cancerH I Scher
The Journal of Urology|November 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaH I Scher
Current Opinion in Oncology|June 1, 1990
Predicting biologic potential in prostate cancerH I Scher
The Journal of Urology|November 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACH I Scher
The Journal of Urology|November 1, 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancerH I Scher
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
JAMA|May 11, 1999
Management of prostate cancer after prostatectomy: treating the patient, not the PSAH I Scher
Seminars in Oncology|October 1, 1994
Prostate cancer: improving the therapeutic indexH I Scher
The New England Journal of Medicine|November 4, 1993
New approaches to the treatment of bladder cancerH I Scher
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Neoadjuvant versus adjuvant chemotherapy in invasive bladder cancerH I Scher
European Urology|January 1, 1996
Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: the argument forH I Scher
Seminars in Oncology|October 1, 1994
Introduction: prostate cancerH I Scher
The Journal of Urology|November 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaH I Scher
Current Opinion in Oncology|June 1, 1990
Predicting biologic potential in prostate cancerH I Scher
The Journal of Urology|November 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACH I Scher
The Journal of Urology|November 1, 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancerH I Scher
Pageof 22